Cepheid Reports Fourth Quarter And Full Year 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall St slides after strong jobs report bolsters hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil slides on Friday, heads for weekly gain on US-Iran fight
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Leerink Partners Reiterates Market Perform on Cepheid (CPHD) Following 4Q
February 3, 2016 8:51 AM ESTLeerink Partners reiterated a Market Perform rating on Cepheid (NASDAQ: CPHD), and cut the price target to $33.00 (from $39.00), following the company's 4Q earnings report. CPHDs reported revenue of $147M was in-line with the Street's forecast of $147M. Higher-than-consensus clinical systems sales were offset... More
Cepheid (CPHD) Reports Q4 EPS of 7c, Offers FY16 Guidance
February 2, 2016 4:15 PM ESTCepheid (NASDAQ: CPHD) reported Q4 EPS of $0.07, may not compare to the analyst estimate of ($0.20). Revenue for the quarter came in at $147 million versus the consensus estimate of $146.91 million.
GUIDANCE:
Cepheid sees FY2016 EPS of $0.22-$0.28, may not compare to... More
